FCA Venture Partners is a venture capital firm specializing in early-stage healthcare technology and technology-enabled healthcare services companies. Established in 1996 and based in Nashville, Tennessee, the firm focuses on investments that improve patient care, reduce costs, and increase efficiency. With a history of over 60 investments in the rapidly evolving healthcare industry, FCA brings valuable healthcare insights, connections, and board-level experience to accelerate growth and build disruptive and sustainable businesses.

The firm's flagship fund invests $3-6 million as the lead investor in Series A rounds or as a participant in Series B rounds, while its seed fund, FCA Health Innovations II, invests $1-4 million per company in Seed and Series A stages. Notable portfolio companies include SonderMind, ProviderTrust, Lumere, Clinical Ink, Javara, SafeRide, and RubiconMD.